2019-01-31 |
128 |
|
the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 8,450,338; US 8,481,083; US…2017
1 February 2019
1:17-cv-00894
835 Patent - Abbreviated New Drug Application(ANDA)
None |
External link to document |
2017-07-05 |
4 |
|
the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 8,450,338; US 8,481,083; US…2017
1 February 2019
1:17-cv-00894
835 Patent - Abbreviated New Drug Application(ANDA)
None |
External link to document |
2017-10-19 |
40 |
|
Initial Infringement Contentions for U.S. Patent NOS. 8,450,338,8,481,083 and 9,669,110 filed by Ferring…2017
1 February 2019
1:17-cv-00894
835 Patent - Abbreviated New Drug Application(ANDA)
None |
External link to document |
2018-04-02 |
59 |
|
2
Patents: 8,450,338 (“the ‘338 patent”), 8,481,083 (“the ‘083 patent”) and 9,669,110
…for infringement of the ‘338 patent, the
‘083 patent, and the ‘110 patent.8 Counts I and II assert respective…the
‘338 patent and the ‘083 patent, and Count III asserts infringement of the ‘110 patent.9
…21 C.F.R. § 314.53, the ‘338 patent and the ‘083 patent are listed in the
FDA’s Approved Drug Products…parties also agree that the ‘110 patent is not an Orange
Book patent for Prepopik®.5
C. Background |
External link to document |
2018-08-08 |
89 |
Notice of Service |
Final Infringement Contentions for U.S. Patent Nos. 8,450,338, 8,481,083, and 9,669,110 filed by Ferring…2017
1 February 2019
1:17-cv-00894
835 Patent - Abbreviated New Drug Application(ANDA)
None |
External link to document |